Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab
Status:
Completed
Trial end date:
2016-11-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain increased knowledge concerning central pain and
fatigue processing in rheumatoid arthritis, and how these conditions are influenced by
treatment with Tumor Necrosis Factor (TNF) blockade with adalimumab.
Phase:
N/A
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Abbott Swedish Foundation for Strategic Research The Swedish Research Council